TipRanks
Go Ultimate55% OFF

Cogent Biosciences (COGT) Balance Sheet

Cogent Biosciences Balance Sheet

Cogent Biosciences's total assets for Q2 2026 were $834.55M, a decrease of 7.58% from the previous quarter. COGT total liabilities were $302.16M for the fiscal quarter, a 2.32% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 937.61M$ 327.90M$ 313.44M$ 300.81M$ 232.09M
$ 301.24M$ 71.61M$ 55.63M$ 45.08M$ 17.91M
$ 636.37M$ 256.29M$ 257.80M$ 255.74M$ 214.18M

Currency in USD

Cogent Biosciences Debt to Assets

0400M800M1.2B0 %15 %30 %45 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets